Open AccessAB065. 137. Clinically relevant chemotherapies promote immune resistance via upregulation of inhibitory immune checkpoints on T-cells and oesophageal adenocarcinoma cells
Author(s) -
Maria Davern,
Emma Foley,
John V. Reynolds,
Stephen E. Maher,
Melissa J. Conroy,
Margaret R. Dunne,
Joanne Lysaght
Publication year - 2019
Publication title -
mesentery and peritoneum
Language(s) - English
Resource type - Journals
ISSN - 2616-2725
DOI - 10.21037/map.2019.ab065
Subject(s) - tigit , immune system , flow cytometry , chemotherapy , medicine , cancer research , pd l1 , downregulation and upregulation , t cell , immunology , immunotherapy , oncology , biology , biochemistry , gene